SCHEDULE 13G Filed 2026-10-23 Event — SEC 0002161951-26-000001 →

Zedek Daniel Clayton → Adicet Bio, Inc. ACET

Stake: — Shares: — Class: Common Stock, $0.0001 par vaue

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Short interest building (+78.5% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.10

485,466 shares short · +78.5% vs prior

Other 13D/G Filings on Adicet Bio, Inc.

Filed	Form	Filer	Stake	Shares
2026-04-10	SCHEDULE 13D/A	ORBIMED ADVISORS LLC	8.80%	844,787	view →
2025-10-10	SCHEDULE	ORBIMED ADVISORS LLC	9.60%	14,772,598	view →
2024-01-29	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-12-14	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-03-16	SC	Abingworth LLP	—	—	view →
2020-12-03	SC	Schindel Yair Chaim	—	—	view →
2019-12-19	SC	PureTech Health LLC	—	—	view →
2019-03-25	SC	ORBIMED ADVISORS LLC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →